Plans to expand the capacity of the Centre for Clinical Haematology at the Queen Elizabeth Hospital, Birmingham have been announced and Cure Leukaemia is calling on all corporate and community supporters to unite and help raise the £3million to establish the Birmingham Institute of Haematology (BIH).
As profiled in the Birmingham Post and Mail today, the BIH will significantly increase the Centre’s ability to employ additional specialist research nurses, open further world first clinical trials, treat more leukaemia patients and, as a result, save more lives.
Professor Charlie Craddock CBE said: “There has been quite remarkable progress in our treatment and understanding of all forms of blood cancer in the last ten years but the time is now for curing blood cancer. The BIH will not only hasten progress towards establishing effective treatments for all blood cancers within our lifetime but also immediately increase the number of lives saved in the process.”
To celebrate the 10th anniversary of the Centre, Cure Leukaemia is focusing its fundraising efforts on the financing of the Centre’s development. Cure Leukaemia chief executive James McLaughlin said: “We already have major corporate and community backing in the last 13 years but to find cures for all blood cancers we need the whole Cure Leukaemia family to unite as one to help Charlie and his team build on their track record of success since 2003."
“The BIH will provide the foundations to accelerate progress towards this inspirational goal and Cure Leukaemia will focus its fundraising efforts on the establishment of the BIH going forward.” We need your help to make this dream a reality. By helping Cure Leukaemia you are contributing to finding a cure for all forms of blood cancer and saving lives in the process.
